Screening for Unhealthy Drug Use: US Preventive Services Task Force Recommendation Statement
- PMID: 32515821
- DOI: 10.1001/jama.2020.8020
Screening for Unhealthy Drug Use: US Preventive Services Task Force Recommendation Statement
Abstract
Importance: An estimated 12% of adults 18 years or older and 8% of adolescents aged 12 to 17 years report unhealthy use of prescription or illegal drugs in the US.
Objective: To update its 2008 recommendation, the USPSTF commissioned reviews of the evidence on screening by asking questions about drug use and interventions for unhealthy drug use in adults and adolescents.
Population: This recommendation statement applies to adults 18 years or older, including pregnant and postpartum persons, and adolescents aged 12 to 17 years in primary care settings. This statement does not apply to adolescents or adults who have a currently diagnosed drug use disorder or are currently undergoing or have been referred for drug use treatment. This statement applies to settings and populations for which services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred.
Evidence assessment: In adults, the USPSTF concludes with moderate certainty that screening by asking questions about unhealthy drug use has moderate net benefit when services for accurate diagnosis of unhealthy drug use or drug use disorders, effective treatment, and appropriate care can be offered or referred. In adolescents, because of the lack of evidence, the USPSTF concludes that the benefits and harms of screening for unhealthy drug use are uncertain and that the balance of benefits and harms cannot be determined.
Recommendation: The USPSTF recommends screening by asking questions about unhealthy drug use in adults 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.) (B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for unhealthy drug use in adolescents. (I statement).
Comment in
-
Screening for Unhealthy Drug Use: Neither an Unreasonable Idea Nor an Evidence-Based Practice.JAMA. 2020 Jun 9;323(22):2263-2265. doi: 10.1001/jama.2019.20152. JAMA. 2020. PMID: 32515804 No abstract available.
-
USPSTF recommends asking adults screening questions about unhealthy drug use.Ann Intern Med. 2020 Oct 20;173(8):JC38. doi: 10.7326/ACPJ202010200-038. Ann Intern Med. 2020. PMID: 33075271
Summary for patients in
-
Screening for Unhealthy Drug Use in Adults and Adolescents.JAMA. 2020 Jun 9;323(22):2350. doi: 10.1001/jama.2020.8192. JAMA. 2020. PMID: 32515816 No abstract available.
Similar articles
-
Screening for Unhealthy Drug Use: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.JAMA. 2020 Jun 9;323(22):2310-2328. doi: 10.1001/jama.2019.21381. JAMA. 2020. PMID: 32515820
-
Screening for Chlamydia and Gonorrhea: US Preventive Services Task Force Recommendation Statement.JAMA. 2021 Sep 14;326(10):949-956. doi: 10.1001/jama.2021.14081. JAMA. 2021. PMID: 34519796
-
Screening and Behavioral Counseling Interventions to Reduce Unhealthy Alcohol Use in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement.JAMA. 2018 Nov 13;320(18):1899-1909. doi: 10.1001/jama.2018.16789. JAMA. 2018. PMID: 30422199
-
Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: US Preventive Services Task Force Recommendation Statement.JAMA. 2022 Jun 21;327(23):2326-2333. doi: 10.1001/jama.2022.8970. JAMA. 2022. PMID: 35727271 Review.
-
Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement.JAMA. 2022 Aug 23;328(8):746-753. doi: 10.1001/jama.2022.13044. JAMA. 2022. PMID: 35997723 Review.
Cited by
-
Implementation of universal screening for substance use in pregnancy in a public healthcare system.AJOG Glob Rep. 2024 Jul 27;4(3):100384. doi: 10.1016/j.xagr.2024.100384. eCollection 2024 Aug. AJOG Glob Rep. 2024. PMID: 39263682 Free PMC article.
-
Emergency Department Screening and Interventions for Adolescents With Substance Use: A Narrative Review.J Emerg Med. 2024 Nov;67(5):e414-e424. doi: 10.1016/j.jemermed.2024.05.012. Epub 2024 Jun 10. J Emerg Med. 2024. PMID: 39242345 Review.
-
Prescription Digital Therapeutics for Substance Use Disorder in Primary Care: Mixed Methods Evaluation of a Pilot Implementation Study.JMIR Form Res. 2024 Sep 2;8:e59088. doi: 10.2196/59088. JMIR Form Res. 2024. PMID: 39222348 Free PMC article.
-
Nurse Practitioner Work Environment and Rural Primary Care for Substance Use.J Nurse Pract. 2024 Oct;20(9):105152. doi: 10.1016/j.nurpra.2024.105152. Epub 2024 Jul 20. J Nurse Pract. 2024. PMID: 39131540
-
Current Cannabis Use Among Adults with Heart Disease in the USA, 2021-2022.J Gen Intern Med. 2024 Nov;39(15):3093-3095. doi: 10.1007/s11606-024-08977-3. Epub 2024 Aug 7. J Gen Intern Med. 2024. PMID: 39112780 No abstract available.
